Junichi Asaka

526 total citations
23 papers, 410 citations indexed

About

Junichi Asaka is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Junichi Asaka has authored 23 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 5 papers in Pediatrics, Perinatology and Child Health and 3 papers in Genetics. Recurrent topics in Junichi Asaka's work include Drug Transport and Resistance Mechanisms (9 papers), Colorectal Cancer Treatments and Studies (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Junichi Asaka is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Colorectal Cancer Treatments and Studies (4 papers) and Pharmacological Effects and Toxicity Studies (4 papers). Junichi Asaka collaborates with scholars based in Japan, Canada and United States. Junichi Asaka's co-authors include Ken‐ichi Inui, Tomohiro Terada, Toshiya Katsura, K. OGASAWARA, Masahiro Tsuda, Ayano Katagiri, Masahiro Okuda, Koichi Iwata, David C. Yeomans and Masamichi Shinoda and has published in prestigious journals such as SHILAP Revista de lepidopterología, Pain and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Junichi Asaka

19 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junichi Asaka Japan 10 244 119 97 57 55 23 410
Kazumi Fujita Japan 7 143 0.6× 70 0.6× 85 0.9× 29 0.5× 39 0.7× 12 368
Spencer C. Yost United States 8 303 1.2× 166 1.4× 262 2.7× 73 1.3× 30 0.5× 9 662
Jun Miura Japan 10 90 0.4× 48 0.4× 49 0.5× 23 0.4× 69 1.3× 24 399
Scott M. Ocheltree United States 11 220 0.9× 96 0.8× 93 1.0× 72 1.3× 40 0.7× 12 454
Päivi Toivonen Finland 11 113 0.5× 42 0.4× 89 0.9× 10 0.2× 38 0.7× 17 484
Hsiang‐Wei Kuo Taiwan 14 60 0.2× 78 0.7× 128 1.3× 11 0.2× 54 1.0× 29 500
Yuka Ikenaga Japan 8 169 0.7× 143 1.2× 129 1.3× 9 0.2× 150 2.7× 11 601
E. Bojesen Denmark 11 50 0.2× 53 0.4× 172 1.8× 28 0.5× 34 0.6× 20 483
Roland Sakiyama United States 9 71 0.3× 52 0.4× 85 0.9× 16 0.3× 19 0.3× 12 393
Rong Zhao China 9 204 0.8× 120 1.0× 79 0.8× 9 0.2× 28 0.5× 16 400

Countries citing papers authored by Junichi Asaka

Since Specialization
Citations

This map shows the geographic impact of Junichi Asaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichi Asaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichi Asaka more than expected).

Fields of papers citing papers by Junichi Asaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junichi Asaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichi Asaka. The network helps show where Junichi Asaka may publish in the future.

Co-authorship network of co-authors of Junichi Asaka

This figure shows the co-authorship network connecting the top 25 collaborators of Junichi Asaka. A scholar is included among the top collaborators of Junichi Asaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junichi Asaka. Junichi Asaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Saito, Yoko, et al.. (2023). Quantitative assessment of skin disorders induced by panitumumab: a prospective observational study. Cancer Chemotherapy and Pharmacology. 93(4). 319–328.
3.
4.
Asaka, Junichi, et al.. (2023). Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone. Supportive Care in Cancer. 31(4). 208–208. 2 indexed citations
5.
Saito, Yoko, et al.. (2022). Effect of risk factors for acneiform rash induced by anti-epidermal growth factor receptor antibody drugs on survival: a retrospective observational study. Journal of Pharmaceutical Health Care and Sciences. 8(1). 22–22. 1 indexed citations
6.
Asaka, Junichi, et al.. (2021). Bevacizumab Increases Endothelin-1 Production via Forkhead Box Protein O1 in Human Glomerular Microvascular Endothelial Cells In Vitro. International Journal of Nephrology. 2021. 1–8. 5 indexed citations
7.
Asaka, Junichi, et al.. (2021). Analysis of risk factors for skin disorders caused by anti‐epidermal growth factor receptor antibody drugs and examination of methods for their avoidance. Journal of Clinical Pharmacy and Therapeutics. 46(5). 1404–1411. 4 indexed citations
8.
9.
10.
Kubo, Asako, Masamichi Shinoda, Ayano Katagiri, et al.. (2017). Oxytocin alleviates orofacial mechanical hypersensitivity associated with infraorbital nerve injury through vasopressin-1A receptors of the rat trigeminal ganglia. Pain. 158(4). 649–659. 67 indexed citations
11.
OGASAWARA, K., Tomohiro Terada, Hideyuki Motohashi, et al.. (2008). Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. Journal of Human Genetics. 53(7). 607–614. 33 indexed citations
12.
Kajiwara, Moto, Tomohiro Terada, Junichi Asaka, et al.. (2008). Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1/SLC22A1). American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(6). G1211–G1216. 17 indexed citations
13.
Asaka, Junichi, Tomohiro Terada, K. OGASAWARA, Toshiya Katsura, & Ken‐ichi Inui. (2007). Characterization of the Basal Promoter Element of Human Organic Cation Transporter 2 Gene. Journal of Pharmacology and Experimental Therapeutics. 321(2). 684–689. 14 indexed citations
14.
Asaka, Junichi, Tomohiro Terada, Masahiro Tsuda, Toshiya Katsura, & Ken‐ichi Inui. (2007). Identification of Essential Histidine and Cysteine Residues of the H+/Organic Cation Antiporter Multidrug and Toxin Extrusion (MATE). Molecular Pharmacology. 71(6). 1487–1493. 27 indexed citations
15.
Kajiwara, Moto, Tomohiro Terada, Junichi Asaka, et al.. (2007). Critical roles of Sp1 in gene expression of human and rat H+/organic cation antiporter MATE1. American Journal of Physiology-Renal Physiology. 293(5). F1564–F1570. 31 indexed citations
16.
OGASAWARA, K., Tomohiro Terada, Junichi Asaka, Toshiya Katsura, & Ken‐ichi Inui. (2007). Hepatocyte nuclear factor-4α regulates the human organic anion transporter 1 gene in the kidney. American Journal of Physiology-Renal Physiology. 292(6). F1819–F1826. 48 indexed citations
17.
Asaka, Junichi, Tomohiro Terada, Masahiro Okuda, Toshiya Katsura, & Ken‐ichi Inui. (2006). Androgen Receptor is Responsible for Rat Organic Cation Transporter 2 Gene Regulation but not for rOCT1 and rOCT3. Pharmaceutical Research. 23(4). 697–704. 47 indexed citations
18.
Tsuda, Masahiro, et al.. (2006). Oppositely directed H+ gradient functions as a driving force of rat H+/organic cation antiporter MATE1. American Journal of Physiology-Renal Physiology. 292(2). F593–F598. 68 indexed citations
19.
OGASAWARA, K., Tomohiro Terada, Junichi Asaka, Toshiya Katsura, & Ken‐ichi Inui. (2006). Human Organic Anion Transporter 3 Gene Is Regulated Constitutively and Inducibly via a cAMP-Response Element. Journal of Pharmacology and Experimental Therapeutics. 319(1). 317–322. 31 indexed citations
20.
Watanabe, Toru, et al.. (2001). Practical Research on Auxiliary Lane Controlling Traffic Lane Distribution. INFRASTRUCTURE PLANNING REVIEW. 18. 927–934.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazumi Fujita Breakdown of academic impact, for papers by Spencer C. Yost Breakdown of academic impact, for papers by Jun Miura Breakdown of academic impact, for papers by Scott M. Ocheltree Breakdown of academic impact, for papers by Päivi Toivonen Breakdown of academic impact, for papers by Hsiang‐Wei Kuo Breakdown of academic impact, for papers by Yuka Ikenaga Breakdown of academic impact, for papers by E. Bojesen Breakdown of academic impact, for papers by Roland Sakiyama Breakdown of academic impact, for papers by Rong Zhao
Rankless by CCL
2026